Exosite Licenses IoT Technology to West Pharmaceutical Services, Inc.
Summary
MINNEAPOLIS--(BUSINESS WIRE)--Exosite LLC, a leading provider in the Industrial Internet of Things (IIoT) market, today announced that it has licensed use of certain software technology and solutions to West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration. Exosite’s technologies have been validated in highly regulated markets similar to West’s and deployed in a variety of public and private cloud environments. "Im confident that our mature technologies will contribute significantly to Wests digital transformation initiatives, and I look forward to the collaboration between our organizations in the coming years. Based in Minneapolis, with offices around the globe, the Exosite team possesses a wealth of experience and expertise in IoT technology and business strategy. Exosite engages with leading manufacturers, providing complete connected solutions, an enterprise software platform, and a rich ecosystem of tools and partnerships to quickly guide connected-product concepts to marketable IoT applications.
Classifications
AskAI Classifications
LabelsLinked Companies
